Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
GERN
GERON CORP
NASDAQ · Pharmaceutical Preparations
Last close
$1.23
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
Pharmaceutical Preparations
Market cap
$790.24M
RECENT INSIDER TRADES
2026-10-01
· Spiegel Robert J.
(Director)
· OTHER
2026-07-01
· Spiegel Robert J.
(Director)
· OTHER
2026-04-01
· Spiegel Robert J.
(Director)
· OTHER
2026-02-19
· ROBERTSON MICHELLE
(EVP, CHIEF FINANCIAL OFFICER)
· SELL
2025-05-13
· LAWLIS V BRYAN
(Director)
· BUY
INSTITUTIONAL OWNERSHIP
Institutional holders
277
Shares held
571,002,236
Value
$893.37M
Percent of shares outstanding
88.88%
As of quarter end
2026-06-30
RECENT NEWS
Did Geron Corporation Insiders Breach their Fiduciary Duties to Shareholders?
Geron Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Geron Corporation - GERN
GERN: Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Geron targets high end of 2026 RYTELO revenue guidance
Geron projects RYTELO revenue near high end of 2026 guidance
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
GERON CORP (GERN) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit